XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.7.0.1

License Agreements | 6 Months Ended
--- | ---
May 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract] |
License Agreements | Note 9 – License Agreements The Company enters into two types of licensing agreements and in both types, the Company earns revenue on the initial license fees. Under the technology agreements, the Company earns processing and storage royalties from the affiliates that process in their own facility. Under the marketing agreements, the Company earns processing and storage revenues from affiliates that store specimens in the Company’s facility in Oldsmar, Florida. Technology Agreements The Company has entered into a definitive License and Royalty Agreement with LifeCell International Private Limited, formerly Asia Cryo-Cell Private Limited, (“LifeCell”) to establish and market its umbilical cord blood and menstrual stem cell programs in India. Per the License and Royalty Agreement with Lifecell, there is a $1 Million cap on the amount of royalties due to the Company per year and a $10 Million cap on the amount of royalties due to the Company for the term of the License and Royalty Agreement. As of May 31, 2017, Lifecell has paid the Company $5.1 Million for royalties due under the terms of the License and Royalty Agreement. Marketing Agreements The Company has definitive license agreements to market the Company’s umbilical cord blood stem cell programs in Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and Pakistan. The following table details the initial license fees for the technology and marketing agreements and processing and storage royalties earned under the technology agreements for the three and six months ended May 31, 2017 and May 31, 2016. The initial license fees and processing and storage royalties are reflected in licensee and royalty income in the accompanying consolidated statements of operations.
Processing and Storage Royalties |
|  | Three Months Ended May 31, 2017 |  |  | Six Months Ended May 31, 2017 |
India |  | $ | 328,669 |  |  | $ | 328,669 |
Total |  | $ | 328,669 |  |  | $ | 328,669 |
|  | Three Months Ended May 31, 2016 |  |  | Six Months Ended May 31, 2016 |
India |  | $ | 356,932 |  |  | $ | 356,932 |
Total |  | $ | 356,932 |  |  | $ | 356,932 |

X
- Definition The entire disclosure for license agreements. + References No definition available. + Details
Name: | ccel_LicenseAgreementsTextBlock
Namespace Prefix: | ccel_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration